Insulet Corp (MIL:1PODD)
€ 140.2 (0%) Market Cap: 10.00 Bil Enterprise Value: 10.41 Bil PE Ratio: 38.27 PB Ratio: 8.75 GF Score: 62/100

Insulet Corp at William Blair Growth Stock Conference Transcript

Jun 03, 2026 / 07:00PM GMT
Release Date Price: €122.55 (-1.17%)
Steven Lichtman
William Blair Capital Partners - Equity Analyst

Good afternoon. My name is Steve Lichtman. I'm the medtech analyst here at William Blair covering our next presenter, Insulet Corporation. Before we kick off the presentation, I'm required to inform you that for a complete list of research disclosures or potential conflicts of interest, please visit our website at williamblair.com.

With that, we're happy to have with us today, Eric Benjamin, Executive Vice President and COO; and Clare Trachtman, VP and Head of Investor Relations. After the presentation here, we'll have a breakout up in the [Jennie A] room.

And with that, I'll turn the mic over to Eric. Thanks.

Eric Benjamin
Insulet Corp - Executive Vice President - Innovation, Strategy and Digital Products

Thanks, Steve. Good afternoon, everyone. It's a pleasure to be here. My name is Eric Benjamin, Chief Operating Officer at Insulet Corporation, and I have had the pleasure of being part of Insulet for almost 11 years.

During this presentation, I'm going to make some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot